Lipid Management Program

A new era of
heart protection,
finally within reach

PCSK9 inhibitors, measured by your labs and managed
by clinicians to maximize their benefit for years.

  • Up to 60% lower LDL

    On top of a statin, by injection or daily pill.

  • Measure beyond LDL

    Retest regularly to track changes over time.

  • Ongoing clinical care

    To keep your numbers low for years.

  • A personalized PCSK9 protocol
  • 60+ biomarkers tested
  • 1:1 care from your clinician and coach
  • Retesting & treatment adjustments
  • A personalized PCSK9 protocol
  • 60+ biomarkers tested
  • 1:1 care from your clinician and coach
  • Retesting & treatment adjustments

$75/month

Just $2.47 a day

Billed annually

Medications billed separately. A prescription isn’t guaranteed.

What we test

  • ApoB
  • Lp(a)
  • LDL Cholesterol
  • +57 more

Why PCSK9 inhibitors

The future of cholesterol treatment is here

For decades, statins set the limit on how low harmful LDL cholesterol could go. PCSK9 inhibitors broke through it.

The discovery

Some people are born protected from heart disease.

Scientists found people whose genes naturally switch off a protein called PCSK9. Their LDL runs low for life, and they have far fewer heart attacks. PCSK9 inhibitors were built to give everyone that same protection.¹

Your cardiovascular trajectory

Age (years)

Illustrative only. Not a prediction of individual outcomes.

What becomes possible

Change your heart’s trajectory

Up to 60%

Deeper LDL lowering

On top of a statin, LDL drops up to 60% further, and ApoB falls with it. Levels once out of reach become normal.²

FOURIER

20%

Fewer heart attacks and strokes

Added to a statin in a 27,000-person trial, with the benefit growing the longer people stayed on it.³

FOURIER · 27,000+ people

Plaque

That shrinks

Added to a statin, PCSK9 treatment helped existing plaque in the arteries regress. It lowers Lp(a) too.⁴

GLAGOV

The earlier LDL comes down and the longer it stays there, the bigger the benefit. That’s what we build your protocol around.

Could a PCSK9 inhibitor be right for you?

Your clinician reviews your labs and cardiovascular risk and decides whether treatment is appropriate.

  1. Genetic studies of people with PCSK9 gene variants that lower LDL from birth. A genetic finding, not a drug result.
  2. LDL cholesterol reduction with evolocumab added to statin therapy in FOURIER (59% at 48 weeks), with a parallel reduction in ApoB.
  3. Repatha plus a statin reduced the relative risk of cardiovascular death, heart attack, or stroke by 20% (composite endpoint). Risk reduction was 16% in year one and 25% thereafter. Follow-up reached ~8 years, including the open-label extension.
  4. GLAGOV: coronary plaque regression with evolocumab plus statin vs. statin alone (64.3% of patients vs. 47.3%). PCSK9 inhibitors also lower Lp(a).

It’s time to see heart health
from every angle.

The full panel

Most care stops at LDL. We look at cholesterol particles, inflammation, and metabolic health together, because that’s how heart disease actually works.

  1. 01

    Cholesterol particles. What builds plaque.

    Particles carrying cholesterol slip into the artery wall and stay there. Lp(a) is the genetic version most people have never tested.

    Tested in your panel
    • ApoB
    • Lp(a)
  2. 02

    Inflammation. What speeds it up.

    Inflammation turns quiet buildup into active plaque, even when LDL looks fine.

    Tested in your panel
    • hs-CRP
  3. 03

    Metabolic health. What wears down the wall.

    Insulin resistance damages the artery lining and stiffens it over time. Fasting insulin can flag it years before blood sugar rises.

    Tested in your panel
    • Fasting insulin
THEN WE MEASURE AGAIN

Your first panel sets your baseline. About 3 months after every change, we retest to show what’s working and adjust what isn’t.

  1. START

    Baseline

    Your first panel sets the starting point.

  2. ≈ 3 MONTHS LATER

    Retest

    See how your markers respond.

  3. AFTER EACH RETEST

    Adjust

    Your clinician fine-tunes your plan.

Expert care that gets your numbers to target, and keeps them there.

Your care team

Our clinicians and coaches turn the latest research on heart disease and aging into a protocol built for your biology, then adjust it until you hit your target.

  1. Clinicians

    A protocol built for your biology

    Clinicians who prescribe, combine, and fine-tune your treatment around your labs and goals.

  2. Expert coaches

    Expert guidance between labs

    Coaches with advanced degrees, guiding nutrition, training, and sleep around your results.

  3. Always learning

    Care that evolves with the science

    As new cardiovascular research emerges, your protocol keeps pace, so you get the best outcome possible.

HSA/FSA eligible

Lipid Management Program

Advanced testing, a clinician, coaching, and retesting, all in one program.

$75/month

Billed annually

Medications billed separately · Prescription not guaranteed · Cancel anytime


  • A personalized PCSK9 protocol
  • 60+ biomarker testing
  • A clinician who sets your targets
  • Retesting as your plan changes
  • Coaching between labs
  • 20% off statins and ezetimibe

Medications billed separately · Prescription not guaranteed · Cancel anytime

5 stars4.7 on Trustpilot20,000+ patients

Your treatment options

Powerful options. Chosen for you.

Your clinician prescribes. Your local pharmacy fills. Medications are billed separately.

PCSK9 inhibitors

Access through program
  • Repatha (evolocumab) autoinjector pen

    Repatha (Evolocumab)

    Injection
    Every 2 weeks or monthly

    The longest outcomes record in its class, with fewer heart attacks and strokes.

    Insurance, at your local pharmacy

  • Lipfendra (enlicitide) pill bottle

    Lipfendra (Enlicitide)

    Pill
    Once daily

    The first oral PCSK9 inhibitor, for people who would rather not inject.

    Insurance, at your local pharmacy

  • Lerochol (lerodalcibep-liga) prefilled syringe with an LIB Therapeutics authentic medication seal

    Lerochol (Lerodalcibep-liga)

    Injection
    Once monthly

    A once-monthly injection with a cash option when insurance won’t cover it.

    $199/mo cash to the manufacturer’s program, or insurance

Foundation therapies

20% off with program
  • Atorvastatin pill bottle in Healthspan packaging

    Atorvastatin

    Pill
    Once daily

    Generic for Lipitor. A proven daily statin that lowers LDL and the risk of heart attack and stroke.

    $39 / 3 mo was $49 · Ships every 3 months

  • Rosuvastatin blister pack in its Healthspan box

    Rosuvastatin

    Pill
    Once daily

    Generic for Crestor. A daily statin dosed around your risk, kidney function, and other medications.

    $39 / 3 mo was $49 · Ships every 3 months

  • Ezetimibe pill bottle

    Ezetimibe

    Pill
    Once daily

    Generic for Zetia. Blocks cholesterol absorption in the gut, often paired with a statin.

    20% off with program

Independent prescribing decisions · We don’t sell PCSK9 inhibitors or profit from them. A clinician decides every prescription.

Questions, answered.

  • A cholesterol-lowering medication that blocks a protein called PCSK9. With less PCSK9, your liver keeps more of the receptors that clear LDL ("bad") cholesterol from your blood. It's available as an injection (Repatha, Lerochol) or a once-daily pill (Lipfendra).

  • Usually not. PCSK9 inhibitors are often added to a statin to lower LDL further, and they can be used on their own if statins don't agree with you. Don't stop or change any medication without talking to your clinician first.

  • Only if it's clinically appropriate. Your clinician reviews your history, lab results, and current medications before prescribing anything, so a prescription isn't guaranteed. You're welcome to share your preferences, and your clinician weighs them alongside your results, risk, and goals.

  • Your membership covers biomarker testing, your clinical team, ongoing guidance, and follow-up retesting. Medications aren't included and are billed separately.

  • Your clinician sends your prescription to your local pharmacy, where insurance may apply, or to the manufacturer's program for Lerochol. We don't sell PCSK9 inhibitors or profit from them. Statins and ezetimibe can be filled through our pharmacy partner.

  • No. It's a separate cash price paid directly to the manufacturer's program. Your $75/mo membership covers testing and clinical care.

  • Follow-up testing shows how your numbers respond, and you review the results with your clinician. Your plan is adjusted over time based on what they show.

  • Possibly. A normal LDL doesn't always mean low risk: ApoB, Lp(a), inflammation, and metabolic health can tell a different story. Testing helps you and your clinician see the full picture.